ArticleClinical rheumatology2026
Circ_0001185 as a novel therapeutic target for lupus nephritis according to ceRNA network comprehensive analysis.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectiveThis study aimed to investigate the regulatory role of circular RNAs (circRNAs) in lupus nephritis (LN) and to explore their potential mechanisms.
methodsRenal tissue circRNA, miRNA, and mRNA expression profiles were obtained from GEO datasets. Differentially expressed RNAs were analyzed using R software to construct a circRNA-miRNA-mRNA network. Functional enrichment analysis was performed. Correlations between key gene expression and clinical features were analyzed using the Nephroseq V5 database and validated by immunohistochemistry in an independent LN cohort. CIBERSORT was used to explore immune cell infiltration and analyze the correlations between key genes and immune cell types.
resultsBased on the predicted correlations among differentially expressed circRNAs, miRNAs, and mRNAs, a ceRNA network was constructed. Among the six circRNAs with multiple miRNA binding sites, circ_0001185, which is derived from the IFNGR2 gene, was predicted to act as a sponge for miR-30b-5p. In the network, miR-30b-5p, miR-33a-3p, and miR-103a-2-5p exhibited the highest node degrees. And NFAT5 was identified as a common downstream target of both miR-30b-5p and miR-103a-2-5p. Analysis of the Nephroseq V5 dataset revealed that elevated expression of IFNGR2 and NFAT5 in renal tissue was negatively correlated with eGFR. Immunohistochemistry showed increased NFAT5 expression in renal tissues of LN patients, particularly in proliferative LN, and which was positively correlation with neutrophil infiltration. Furthermore, activated dendritic cells and naive CD4 + T cells showed a positive correlation in CIBERSORT analysis.
conclusionThis study constructed a circRNA-miRNA-mRNA ceRNA network and identified a potential circ_0001185/miR-30b-5p/NFAT5 regulatory axis in LN. Bioinformatic analysis suggested that circ_0001185 may have peptide-coding potential, a preliminary observation that warrants further exploration. Together, these findings identify circ_0001185 as a candidate for future functional studies to evaluate its therapeutic potential. Key Points • This study identifies a potential circ_0001185/miR-30b-5p/NFAT5 regulatory axis in LN, which may be associated with Th17 cell differentiation. IFNGR2 and NFAT5 are associated with eGFR, and bioinformatic analysis raises the possibility that circ_0001185 may have peptide-coding potential, suggesting it warrants further exploration as a candidate for therapeutic investigation.
Indexed as
Identifiers
42026388What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.